Genetic variation and the risk of acute lymphoblastic leukemia

Leukemia Research

Volumn 34, Issue 10, 2010, Pages 1269-1270

  Mullighan, Charles G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AT RICH INTERACTIVE DOMAIN 5B TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN EPSILON; IKAROS TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RISK; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; COPY NUMBER VARIATION; EDITORIAL; ETHNIC DIFFERENCE; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; LEUKEMOGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IKAROS TRANSCRIPTION FACTOR; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK; TRANSCRIPTION FACTORS;

EID: 77955985136     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.05.013     Document Type: Editorial

References (25)

1. Pui C.H., Robison L.L., Look A.T. Acute lymphoblastic leukaemia. Lancet 2008, 371(9617):1030-1043.
2. Pui C.H., Relling M.V., Downing J.R. Acute lymphoblastic leukemia. N Engl J Med 2004, 350(15):1535-1548.
3. Mullighan C.G., Downing J.R. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009, 23(7):1209-1218.
4. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007, 446(7137):758-764.
5. Kuiper R.P., Schoenmakers E.F., van Reijmersdal S.V., Hehir-Kwa J.Y., van Kessel A.G., van Leeuwen F.N., et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 2007, 21(6):1258-1266.
6. Kawamata N., Ogawa S., Zimmermann M., Kato M., Sanada M., Hemminki K., et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 2008, 111(2):776-784.
7. Mullighan C.G., Miller C.B., Radtke I., Phillips L.A., Dalton J., Ma J., et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008, 453(7191):110-114.
8. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia. N Engl J Med 2009, 360:470-480.
9. Hemminki K., Jiang Y. Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database. Leukemia 2002, 16(2):297-298.
10. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006, 6(3):193-203.
11. de Jonge R., Tissing W.J., Hooijberg J.H., Jansen G., Kaspers G.J., Lindemans J., et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009, 113(10):2284-2289.
12. Healy J., Belanger H., Beaulieu P., Lariviere M., Labuda D., Sinnett D. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood 2007, 109(2):683-692.
13. Dong L.M., Potter J.D., White E., Ulrich C.M., Cardon L.R., Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008, 299(20):2423-2436.
14. Han S., Lee K.-M., Park S.K., Lee J.E., Ahn H.S., Shin H.Y., et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 2010, 34:1271-1274.
15. Trevino L.R., Yang W., French D., Hunger S.P., Carroll W.L., Devidas M., et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1001-1005.
16. Papaemmanuil E., Hosking F.J., Vijayakrishnan J., Price A., Olver B., Sheridan E., et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1006-1010.
17. Prasad R.B., Hosking F.J., Vijayakrishnan J., Papaemmanuil E., Koehler R., Greaves M., et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010, 115(9):1765-1767.
18. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994, 79(1):143-156.
19. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007, 109(8):3451-3461.
20. Lahoud M.H., Ristevski S., Venter D.J., Jermiin L.S., Bertoncello I., Zavarsek S., et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 2001, 11(8):1327-1334.
21. Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 2009; 114(10):2159-67.
22. Kuiper R.P., Waanders E., van der Velden V.H., van Reijmersdal S.V., Venkatachalam R., Scheijen B., et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 2010, doi:10.1038/leu.2010.87.
23. Mullighan C.G., Zhang J., Harvey R.C., Collins-Underwood J.R., Schulman B.A., Phillips L.A., et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2009, 106:9414-9418.
24. Yang W, Trevino LR, Yang JJ, Scheet P, Pui CH, Evans WE, et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 2010;Epub; doi:10.1038/leu.2009.277.
25. Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010; doi:10.1182/blood-2009-09-245944.